ICCC Immucell Dashboard

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Company profile

Ticker

ICCC

Exchange

NASDAQ

Website

www.immucell.com/

CEO

Michael Brigham

Incorporated

Delaware

Location

Maine

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances

Idexx Laboratories • Myriad Genetics • Lantheus • Quidel • Neogen • Meridian Bioscience • Celldex Therapeutics • Oxford Immunotec Global • Achieve Life Sciences • Intellia Therapeutics ...

SEC CIK

0000811641

Corporate docs

Articles of Incorporation & Bylaws

IRS number

10382980

ICCC stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts

23 Feb 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 22)

ImmuCell Q4 EPS $0.03 Up From $(0.04) YoY, Sales $3.74M Miss $4.00M Estimate

22 Feb 21

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.03 per share. This is a 175 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $3.74

Earnings Scheduled For February 22, 2021

22 Feb 21

Companies Reporting Before The Bell • Cooper Tire & Rubber (NYSE:CTB) is projected to report quarterly earnings at $0.92 per share on revenue of $732.68 million.

88 Biggest Movers From Friday

1 Feb 21

Stocks That Hit 52-Week Highs On Friday

29 Jan 21

Press releases

Pro users get this 30m faster

ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021

7 Apr 21

PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and

ImmuCell Corp. to Host Earnings Call

23 Feb 21

NEW YORK, NY / ACCESSWIRE / February 23, 2021 / ImmuCell Corp. (NASDAQ:ICCC) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 23, 2021 at 9:00 AM Eastern Time.To

ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020

22 Feb 21

PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020

16 Feb 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

30 Mar 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart ICCC financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Immucell earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	6.95M	6.95M	6.95M	6.95M	6.95M	6.95M
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	211.45K	127.18K	(positive/no burn)	(positive/no burn)
Cash used (since last report)	n/a	n/a	730.89K	439.6K	n/a	n/a
Cash remaining	n/a	n/a	6.22M	6.51M	n/a	n/a
Runway (months of cash)	n/a	n/a	29.4	51.2	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

ICCC insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
8 Dec 20	Bobbi Jo Brockmann	Common Stock, par value $0.10 per share	Grant	Aquire A	No	No	3.15	4,742	14.94K	8,521
8 Dec 20	Bobbi Jo Brockmann	Incentive Stock Options Common Stock	Sale back to company	Dispose D	No	No	3.15	5,258	16.56K	-
12 Mar 20	David Cunningham	Common Stock, par value $0.10 per share	Buy	Aquire P	No	No	4	2,000	8K	15,000
11 Mar 20	David Scott Tomsche	Common Stock, par value $0.10 per share	Buy	Aquire P	No	No	4.28	4,600	19.69K	85,519
27 Feb 20	David Scott Tomsche	Common Stock, par value $0.10 per share	Buy	Aquire P	No	No	4.98	5,130	25.55K	80,919
11 Dec 19	Elizabeth Luttrell Williams	Incentive Stock Options Common Stock	Grant	Aquire A	No	No	5.175	10,000	51.75K	10,000

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

ICCC institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

10.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	25	27	-7.4%
Opened positions	2	4	-50.0%
Closed positions	4	1	+300.0%
Increased positions	5	2	+150.0%
Reduced positions	4	6	-33.3%

13F shares	Current	Prev Q	Change
Total value	4.31M	3.88M	+11.2%
Total shares	724K	714.38K	+1.3%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Renaissance Technologies	168.15K	$1M	+7.7%
Vanguard	93.38K	$556K	0.0%
Overbrook Management	88.03K	$524K	0.0%
MS Morgan Stanley	57.57K	$343K	0.0%
Perritt Capital Management	55K	$327K	-8.3%
Shufro Rose & Co	50.67K	$301K	0.0%
Strategic Financial Services, Inc,	30.03K	$179K	0.0%
HM Payson & Co	20.5K	$122K	-30.5%
Geode Capital Management	20.43K	$121K	0.0%
BLK Blackrock	17.49K	$105K	+4.5%

Largest transactions	Shares	Bought/sold	Change
Essex Financial Services	0	-20K	EXIT
Prosperity Planning	15K	+15K	NEW
Renaissance Technologies	168.15K	+12.03K	+7.7%
Envestnet Asset Management	11.2K	+11.2K	NEW
HM Payson & Co	20.5K	-9K	-30.5%
Perritt Capital Management	55K	-5K	-8.3%
HighTower Advisors	16.87K	+3.5K	+26.2%
NTRS Northern Trust	12.87K	+1.27K	+11.0%
UBS UBS Group AG - Registered Shares	3.37K	+1.05K	+45.4%
C Citigroup	0	-930	EXIT

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Pfizer • Zoetis

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: abnormal, accrual, ago, aspect, automatically, Basse, behavior, belief, borrowing, bridge, broader, buildup, California, cancel, cancelled, candidate, Consumer, corridor, COVID, curtailing, deeper, deliberate, depleted, devaluation, DHIA, diagnose, dumped, dumping, dysgalactiae, ease, eased, easily, educating, embrace, expended, expiry, explore, extra, fabrication, Facilitation, FD, flexibility, fluctuation, forgiven, Gloria, GSB, guideline, hard, home, implicit, indirect, inducing, Interbank, knock, landlord, learning, leasehold, length, lessee, load, London, lunch, methodology, moderately, motivate, motivated, neutralization, notably, online, Overview, parking, particle, Paycheck, payroll, penalty, PPP, predecessor, prepay, proceeding, prudent, recovered, recurring, Reform, relieved, remote, road, ROU, sensitivity, situation, stay, subordinated, superseded, throughput, understood, unmet, unstable, urgent, virtual, visual, VLP, waive

Removed: accepting, Accountingto, adjusted, Amherst, andCMT, annually, antibacterial, apply, assigned, award, bear, bioterrorism, bivalentFirst, bull, byFirst, China, clarity, combating, comply, consolidated, contemplate, converted, corroborated, designated, developedCalifornia, disposed, diversity, dominated, Europe, expandingFirst, FASBAccounting, floating, flow, formally, formulating, hedged, hedging, housing, IMMUNITYtrademark, inPart, integration, introducedFirst, machinery, Mankato, MN, modification, necessarily, norm, notional, offersImmediate, ofFirst, offsetting, ourfirst, ourIMMEDIATE, overvalued, peptide, problematic, provideImmediate, renewed, returned, reviewPart, Ridley, risen, save, sellFirst, slightly, terrorism, thatFirst, theE, thefirst, threat, unaudited, underpart, understand, unusually, USA, weakened, withFirst, withPart

From filing 10-K 2020 FY